Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Catherine L. Nutt"'
Autor:
David N. Louis, Catherine L. Nutt, Ken Aldape, A. John Iafrate, Daniel P. Cahill, Jiangyong Miao, Stephen Yip
Purpose: Over the past few years, the alkylating agent temozolomide has become the standard-of-care therapy for patients with glioblastoma, the most common brain tumor. Recently, large-scale cancer genome sequencing efforts have identified a hypermut
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d16e03b0b0450f51844d5c22996700b
https://doi.org/10.1158/1078-0432.c.6517996.v1
https://doi.org/10.1158/1078-0432.c.6517996.v1
Autor:
David N. Louis, Catherine L. Nutt, Ken Aldape, A. John Iafrate, Daniel P. Cahill, Jiangyong Miao, Stephen Yip
Supplementary Data from MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4d7e240e9196396acd9111a9e08ed9
https://doi.org/10.1158/1078-0432.22440700.v1
https://doi.org/10.1158/1078-0432.22440700.v1
Supplementary Figure S1 from Autocrine Platelet-Derived Growth Factor–Dependent Gene Expression in Glioblastoma Cells Is Mediated Largely by Activation of the Transcription Factor Sterol Regulatory Element Binding Protein and Is Associated with Alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9aed3c65912edc93116a46b8432c294d
https://doi.org/10.1158/0008-5472.22363520
https://doi.org/10.1158/0008-5472.22363520
A complex profile of gene expression elicited by autocrine platelet-derived growth factor (PDGF) signaling was identified in U87 MG glioblastoma cells by microarray analysis. The most striking pattern observed was a PDGF-dependent activation of at le
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4696600b3c3eb2ce80446bea69bf0a7
https://doi.org/10.1158/0008-5472.c.6493748.v1
https://doi.org/10.1158/0008-5472.c.6493748.v1
Supplementary Table 2 from Autocrine Platelet-Derived Growth Factor–Dependent Gene Expression in Glioblastoma Cells Is Mediated Largely by Activation of the Transcription Factor Sterol Regulatory Element Binding Protein and Is Associated with Alter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319d37a6fceeac4c877819a0b12224b9
https://doi.org/10.1158/0008-5472.22363517.v1
https://doi.org/10.1158/0008-5472.22363517.v1
Supplementary Table S1A from Autocrine Platelet-Derived Growth Factor–Dependent Gene Expression in Glioblastoma Cells Is Mediated Largely by Activation of the Transcription Factor Sterol Regulatory Element Binding Protein and Is Associated with Alt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::64d70a3e6a1544ffe203ed6348a8ae93
https://doi.org/10.1158/0008-5472.22363514
https://doi.org/10.1158/0008-5472.22363514
Autor:
Rebecca A. Betensky, Brent A. Coull, E. Andres Houseman, Catherine L. Nutt, Stacia M. DeSantis
Publikováno v:
Statistics in Medicine. 31:1342-1360
High-grade gliomas are the most common primary brain tumors in adults and are typically diagnosed using histopathology. However, these diagnostic categories are highly heterogeneous and do not always correlate well with survival. In an attempt to ref
Publikováno v:
Current Cancer Therapy Reviews. 7:65-77
Autor:
Sandra Camelo-Piragua, Arjola K. Cosper, Michael Jansen, James Kim, David N. Louis, Catherine L. Nutt, A. John Iafrate, Aniruddha Ganguly, Dora Dias-Santagata
Publikováno v:
Journal of Neuropathology & Experimental Neurology. 70:110-115
One of the major challenges of surgical neuropathology is the distinction of diffuse astrocytoma (World Health Organization grade II) from astrocytosis. The most commonly used ancillary tool to solve this problem is p53 immunohistochemistry (IHC), bu
Autor:
Christopher E. Pelloski, Robert B. Jenkins, J. Gregory Cairncross, Heidi S. Phillips, Catherine L. Nutt, Li Zhang, Arnab Chakravarti, Mark R. Gilbert, Krishna P. Bhat, J. Matthew McDonald, Kenneth Aldape, David N. Louis, Howard Colman, Erik P. Sulman, Nasrin Latif Shooshtari, Minesh P. Mehta, Burt G. Feuerstein, Sonya Popoff, Andreana L. Rivera
Publikováno v:
Neuro-Oncology. 12:49-57
Only a subset of patients with newly diagnosed glioblastoma (GBM) exhibit a response to standard therapy. To date, a biomarker panel with predictive power to distinguish treatment sensitive from treatment refractory GBM tumors does not exist. An anal